Suppr超能文献

抑制谷氨酸摄取会导致房水蛋白急性增加。

Inhibition of glutamate uptake causes an acute increase in aqueous humor protein.

作者信息

Langford M P, Berg M E, Mack J H, Ganley J P, Welbourne T C

机构信息

Department of Ophthalmology, Louisiana State University Medical Center, Shreveport, USA.

出版信息

Exp Eye Res. 1997 Feb;64(2):157-65. doi: 10.1006/exer.1996.0180.

Abstract

Inhibition of glutamate transport has been shown to increase paracellular permeability of epithelial cell monolayers in vitro. To determine if blocking glutamate transport would affect tissue permeability in vivo, D-aspartate (D-Asp; 300 nmol 30 microliters-1) (a non-toxic competitive inhibitor of glutamate transport) or a placebo was injected into the anterior chambers of the fellow eyes of 15 adult rabbits. [14C]-L-glucose and/or [125I]-rabbit albumin were included in the injection vehicle as aqueous humor (AH) outflow markers. The specific inhibition of glutamate uptake by D-Asp was indicated by a 15% increase in AH glutamate (174 +/- 9 nmol ml-1 to 205 +/- 13 nmol ml-1; P = 0.03) at 1-1.5 hr post injection. Also, the efflux of [14C]-L-glucose and [125I]-rabbit albumin from the AH of D-Asp injected eyes was increased 22% over the placebo-injected control eyes (P < or = 0.02). Concomitantly, the total protein concentration in the AH from D-Asp injected eyes (517 +/- 35 micrograms ml-1) was 19% greater (P < 0.02) than the protein concentration in AH from placebo-injected control eyes (420 +/- 36 micrograms ml-1). In additional studies, an irreversible inhibitor of glutamate transport, threo-beta-hydroxyaspartate (THA; 30 nmol 30 microliters-1), was shown to increase the efflux of [14C]-L-glucose (22%; P < 0.05) from the anterior chamber and increase AH protein concentrations by 29% (484 +/- 112 micrograms ml-1 in control AH versus 686 +/- 117 micrograms ml-1 in THA AH, P = 0.08) at 1 hr post intracameral injection. SDS-PAGE analysis of the AH associated the protein increase in the D-Asp and THA injected eyes but not placebo-injected control eyes with a detectable increase in a 66 kDa protein (aligns with serum albumin) and several lower molecular weight (23-35 kDa) AH proteins. The results found suggest that inhibition of glutamate transport from the AH acutely increases intraocular epithelial/endothelial paracellular permeability.

摘要

在体外实验中,已证实抑制谷氨酸转运可增加上皮细胞单层的细胞旁通透性。为确定阻断谷氨酸转运是否会影响体内组织的通透性,将D - 天冬氨酸(D - Asp;300 nmol 30微升-1)(一种无毒的谷氨酸转运竞争性抑制剂)或安慰剂注入15只成年兔对侧眼的前房。注射剂中加入[14C] - L - 葡萄糖和/或[125I] - 兔白蛋白作为房水(AH)流出标志物。注射后1 - 1.5小时,D - Asp对谷氨酸摄取的特异性抑制表现为AH中谷氨酸增加15%(从174±9 nmol/ml增加到205±13 nmol/ml;P = 0.03)。此外,与注射安慰剂的对照眼相比,注射D - Asp的眼中[14C] - L - 葡萄糖和[125I] - 兔白蛋白从AH中的流出增加了22%(P≤0.02)。同时,注射D - Asp的眼中AH的总蛋白浓度(517±35微克/毫升)比注射安慰剂的对照眼中AH的蛋白浓度(420±36微克/毫升)高19%(P < 0.02)。在其他研究中,一种不可逆的谷氨酸转运抑制剂,苏式 - β - 羟基天冬氨酸(THA;30 nmol 30微升-1),显示可增加前房中[14C] - L - 葡萄糖的流出(22%;P < 0.05),并在眼内注射后1小时使AH蛋白浓度增加29%(对照AH中为484±112微克/毫升,THA处理的AH中为686±117微克/毫升,P = 0.08)。对AH进行的SDS - PAGE分析表明,注射D - Asp和THA的眼中蛋白增加,但注射安慰剂的对照眼中未增加,这与一种66 kDa蛋白(与血清白蛋白一致)和几种较低分子量(23 - 35 kDa)的AH蛋白的可检测增加有关。研究结果表明,抑制AH中的谷氨酸转运可急性增加眼内上皮/内皮细胞旁通透性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验